Moteur de recherche d’entreprises européennes
Financement de l’UE (5 998 456 €) : Infrastructure commune pour les cohortes nationales en Europe, au Canada et en Afrique Hor 01/01/2019 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Infrastructure commune pour les cohortes nationales en Europe, au Canada et en Afrique
Thousands of human genomes and other biomolecular datasets are now being generated in health, rather than research contexts. Centralised storage and analysis of these is no longer technically feasible for data harmonisation, curation, sharing or analysis and ethical, legal, social reasons. CINECA’s vision is a federated cloud enabled infrastructure making population scale genomic and biomolecular data accessible across international borders, accelerating research, and improving the health of individuals across continents. CINECA will leverage international investment in human cohort studies from Europe, Canada, and Africa to deliver a paradigm shift of federated research and clinical applications. The CINECA consortium will create one of the largest cross-continental implementations of human genetic and phenotypic data federation and interoperability with a focus on common (complex) disease, one of the world’s most significant health burdens. The partners represent a unique combination of scientific excellence with experience of eleven diverse cohorts and scientific projects such as the European Genome-phenome Archive, CanDIG, and H3Africa. CINECA has assembled a virtual cohort of 1.4M individuals from population, longitudinal and disease studies. Federated analyses will deliver new scientific knowledge, harmonisation strategies and the necessary ELSI framework supporting data exchange across legal jurisdictions enabling federated analyses in the cloud. CINECA will provide a template to achieve virtual longitudinal and disease specific cohorts of millions of samples, to advance benefits to patients. CINECA will leverage partner membership of standards and infrastructures like the Global Alliance for Global Health, BBMRI, ELIXIR, and EOSC driving the state of the art in standards development, technical implementation and FAIR data.
| Academisch Ziekenhuis Groningen | 576 375 € |
| Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) | 350 099 € |
| Clinicageno Ltd. | 228 375 € |
| CSC-Tieteen Tietotekniikan Keskus Oy | 491 455 € |
| Erasmus Universitair Medisch Centrum Rotterdam | 464 110 € |
| European Molecular Biology Laboratory | 1 548 809 € |
| Fundacio Centre de Regulacio Genomica | 185 750 € |
| Haute Ecole Specialisee DE Suisse Occidentale | 647 500 € |
| Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit UND Umwelt GmbH | 218 992 € |
| Institut National de la Sante et de la Recherche Medicale | 152 918 € |
| Masarykova Univerzita | 163 000 € |
| Royal Institution FOR THE Advancement OF Learning Mcgill University | 0,00 € |
| SIB Swiss Institute OF Bioinformatics | 279 250 € |
| Simon Fraser University | 0,00 € |
| Tartu Ulikool | 206 250 € |
| The Chancellor, Masters and Scholars of the University of Oxford | 1 058,39 € |
| The Hospital for Sick Children | 0,00 € |
| THE Hyve B.V. | 211 618 € |
| University OF Cape Town | 272 899 € |
https://cordis.europa.eu/project/id/825775
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.